Quidel Corp (QDEL) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Quidel Reports Fourth Quarter and Full Year 2015 Financial Results
February 17, 2016 4:10 PM ESTSAN DIEGO, CA -- (Marketwired) -- 02/17/16 -- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and year ended December 31, 2015.
Fourth Quarter 2015 Highlights:
Total revenues were $52.4 million as compared to $64.0 million in the fourth quarter of 2014. Total influenza revenues decreased 33% from the fourth quarter of 2014 to $24.3 million. Revenues from new products were 34% of total revenue in the... More


